Faster drug approvals need safety measures
The Atlanta Journal-Constitution’s article on the FDA’s new expedited review program highlights the agency’s goal to bring lifesaving drugs to patients faster. While that urgency is understandable, it raises important questions about how safety and accountability will be maintained when reviews are shortened to just one or two months.
The FDA has faced criticism in the past for approving medications through accelerated pathways that were later withdrawn when follow-up studies failed to confirm benefits. Faster programs often rely on early or limited trial data, which can overlook long-term risks or exaggerate short-term results. If this new initiative is to build public trust, post-market monitoring should be treated as a vital safeguard rather than a procedural step.
The agency should also increase transparency by explaining how it selects “national priority” drugs and how it evaluates early trial data. These steps would protect patients while allowing innovation to move forward responsibly. Expedited review can serve both innovation and safety if the FDA continues to make public health its highest standard.
NIHA SAVILI, ATLANTA
Trump’s remarks about antifa not connected to facts
Yes, I’m an anti-fascist. Why do you ask?
I was born during World War II. My early years informed me how the fascists of Europe used their concentrated political power to slaughter Jews, gays, gypsies, unionists, and other minorities who didn’t conform to their rigid beliefs. My father, a U.S. Army veteran, pointed out that we also had fascists at home, many of whom were among the worst anti-black racists.
At home or abroad, fascism — or severe authoritarianism — has tied itself closely to the wealthiest individuals and most powerful corporations.
Perhaps you’re puzzled about President Donald Trump’s announcements that he would prosecute people whom he labeled “antifa.” I don’t think there’s any organization of that name, but the term is short for “anti-fascists.”
Sadly, our President’s rhetoric is not well-connected to facts. His political appointees and social companions, however, demonstrate his links with very rich persons and titans of industry.
I imagine Mr. Trump wants to punish those he thinks are opposed to fascism. That would be me and nearly all caring people.
HENRY KAHN, ATLANTA
Keep Reading
The Latest
Featured
